We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GTLB:NASDAQGitLab Inc. Analysis

Data as of 2026-04-07 - not real-time

$22.76

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

GitLab (GTLB) is trading at $22.76, just above its 20‑day SMA ($22.23) but well below the 50‑day ($27.01) and 200‑day ($39.45) averages, indicating short‑term momentum but a longer‑term bearish backdrop. The stock sits near its technical support at $20.20 with resistance around $24.83, while the RSI of 44.7 suggests neutral pricing and a bullish MACD histogram (+0.44) hints at a possible near‑term upside. Volatility remains high at nearly 60% over the past 30 days and a beta of ~1.42 points to heightened market sensitivity, yet the company boasts strong fundamentals: 23% YoY revenue growth, an 87% gross margin, positive free cash flow of $283 M, and a cash pile exceeding $1.2 B with zero debt. A DCF‑derived fair value of $64.67 implies roughly 50% upside, far outpacing the industry’s average forward P/E of 32.5, and analysts collectively rate the stock as a “Buy” with a mean target of $34.2.
The recent earnings release highlighted robust ARR expansion and the launch of a share‑repurchase program, reinforcing confidence in cash generation and shareholder returns. Despite current operating losses, the forward EPS projection of $1.02 and a solid cash runway position GitLab for a turnaround, especially as it expands its AI‑driven DevSecOps platform. Given the valuation gap, cash strength, and strategic growth initiatives, the stock presents a compelling case for investors with a higher risk tolerance seeking long‑term upside.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price marginally above 20‑day SMA and near support level
  • Bullish MACD histogram despite broader bearish trend
  • High short‑term volatility and decreasing volume

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF upside of ~50% and forward P/E below industry average
  • Strong revenue growth (23%) and robust free cash flow
  • Share‑repurchase program signaling confidence in balance sheet

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Strategic expansion of AI‑enabled DevSecOps platform
  • Large cash cushion with zero debt supporting future investment
  • Significant valuation gap to fair value providing long‑term upside

Key Metrics & Analysis

Financial Health

Revenue Growth23.20%
Profit Margin-5.86%
P/E Ratio22.3
ROE-6.30%
ROA-2.72%
P/B Ratio3.9
Op. Cash Flow$232.9M
Free Cash Flow$283.1M
Industry P/E32.5

Technical Analysis

TrendBearish
RSI44.7
Support$20.20
Resistance$24.83
MA 20$22.23
MA 50$27.01
MA 200$39.45
MACDBullish
VolumeDecreasing
Fear & Greed Index76.52

Valuation

Fair Value$64.67
Target Price$34.20
Upside/Downside50.26%
GradeUndervalued
TypeBlend

Risk Assessment

Beta1.42
Volatility59.67%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.